# SAM #36E79727R0001

VA procurement for annual supplies of 300 mcg and 480 mcg filgrastim or biosimilar syringes

**Buyer:** VA National Acquisition Center Pharmaceuticals
**Posted:** November 09, 2026
**Respond By:** December 15, 2026
**Identifier:** 36E79727R0001
**NAICS:** 325412, 325414, 424210

The Department of Veterans Affairs is seeking filgrastim syringes or biosimilars for participating federal healthcare users.
- **Government buyer:** Department of Veterans Affairs (VA), Enterprise Procurement Office, OPAL/National Acquisition Center; buyer contact: Dov Vysnia. Intended users include VA, DoD, BOP, IHS, and FHCC.
- **OEMs and vendors:** No manufacturers or vendors are named in the notice or attachment. The procurement requests filgrastim or a biosimilar.
- **Products and estimated annual quantities:**
  - 22,665 non-safety 300 mcg syringes, or biosimilar; one syringe per package.
  - 29,170 non-safety 480 mcg syringes, or biosimilar; one syringe per package.
- **Requirements:** Syringes must be labeled for patient or caregiver use. Offerors must identify the exact product name and provide a unique NDC. One contract is planned to support uninterrupted supply.
- **Period of performance:** One base year with four pre-priced one-year options.
- **Potential competing manufacturers and products:** Amgen (Neupogen), Sandoz (Zarxio), and Pfizer (Nivestym). These companies and products are potential alternatives, not named offerors.

### Description

<p>Please see attached documents.&nbsp;</p>

[View original listing](https://sam.gov/opp/f6209618c8914b9c9d0453cf66a3a9ee/view)